AHA yesterday expressed concern that certain enforcement mechanisms contemplated for health care providers to further interoperability in the 21st Century Cures legislation are inappropriate and could have significant unintended consequences. “We appreciate the inclusion of provisions to further interoperability in Subtitle A of Title III of the 21st Century Cures legislation,” AHA Executive Vice President Rick Pollack said in a letter to the House Energy and Commerce Committee. “However, we are concerned that the heavy-handed and duplicative enforcement mechanisms contemplated for providers could have significant unintended consequences, including undermining new models of care and setting up an environment where well-intentioned providers face significant penalties for small mistakes.” He added, “We appreciate your intent to hold vendors accountable for the design and marketing of interoperable products, and recommend that you ask the Federal Trade Commission to conduct a study of anti-competitive behavior by EHR vendors.” In addition, he said, “we still lack significant technical capabilities and infrastructure to support efficient and effective health information exchange. We believe that there are positive steps that would further our shared goals, such as more robust testing of health information technology products and greater commitment to developing and maturing data standards.”

Related News Articles

Headline
A Health-ISAC (Information Sharing and Analysis Center) bulletin released Oct. 1 warns of a recently released LockBit 5.0 ransomware variant that poses a…
Headline
The Department of Health and Human Services announced Sept. 30 that it is doubling its funding for childhood cancer research from $50 million to $100 million…
Headline
Fernando Martinez, Ph.D., chief digital officer at the Texas Hospital Association, shares how Texas and the THA are building regional resilience through cyber…
Headline
The federal government shut down Oct. 1 following a failed Senate vote on the House-passed continuing resolution to fund the government by midnight Sept. 30.…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Office of Science and Technology Policy issued a request for information Sept. 26 seeking feedback on federal regulations that hinder AI development,…